Therapeutic management of congenital forms of endocrine hypertension
European Journal of Endocrinology · 2023
DOI: 10.1093/ejendo/lvad140 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift European Journal of Endocrinology, 2023. Verfasst von Suranut Charoensri und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology and Metabolism, Department of Medicine, Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand. Hauptthemen laut MEDLINE: Hypertension, Hyperaldosteronism, Mineralocorticoid Excess Syndrome, Apparent, Adrenal Hyperplasia, Congenital. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 127 Literaturangaben. Gefördert von: US Veterans Affairs research.
Abstract (Originalsprache)
Congenital forms of endocrine hypertension are rare and potentially life-threatening disorders, primarily caused by genetic defects affecting adrenal steroid synthesis and activation pathways. These conditions exhibit diverse clinical manifestations, which can be distinguished by their unique molecular mechanisms and steroid profiles. Timely diagnosis and customized management approach are crucial to mitigate unfavorable outcomes associated with uncontrolled hypertension and other related conditions. Treatment options for these disorders depend on the distinct underlying pathophysiology, which involves specific pharmacological therapies or surgical adrenalectomy in some instances. This review article summarizes the current state of knowledge on the therapeutic management of congenital forms of endocrine hypertension, focusing on familial hyperaldosteronism (FH), congenital adrenal hyperplasia, apparent mineralocorticoid excess, and Liddle syndrome. We provide an overview of the genetic and molecular pathogenesis underlying each disorder, describe the clinical features, and discuss the various therapeutic approaches available and their risk of adverse effects, aiming to improve outcomes in patients with these rare and complex conditions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Endocrinology and Metabolism, Department of Medicine, Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand.
- Division of Metabolism, Endocrinology, and Diabetes, Department of Internal Medicine, University of Michigan, Ann Arbor, MI 48109, United States.
- Department of Pharmacology, University of Michigan, Ann Arbor, MI 48109, United States.
- Endocrinology & Metabolism Section, Medicine Service, LTC Charles S. Kettles VA Medical Center, Ann Arbor, MI 48104, United States.
ORCID-Profile: Richard J Auchus
Förderung
- US Veterans Affairs research
Zitieren
APA
Charoensri, S., & Auchus, R. J. (2023). Therapeutic management of congenital forms of endocrine hypertension. European Journal of Endocrinology. https://doi.org/10.1093/ejendo/lvad140
Vancouver
Charoensri S, Auchus RJ. Therapeutic management of congenital forms of endocrine hypertension. European Journal of Endocrinology. 2023. doi:10.1093/ejendo/lvad140
BibTeX
@article{Charoensri2023,
author = {Charoensri, Suranut and Auchus, Richard J},
title = {Therapeutic management of congenital forms of endocrine hypertension},
journal = {European Journal of Endocrinology},
year = {2023},
doi = {10.1093/ejendo/lvad140}
}
EUVIMED